Rapt Therapeutics (RAPT) PT Raised to $55 at UBS

July 6, 2021 4:07 PM EDT Send to a Friend

UBS analyst Navin Jacob raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Rapt Therapeutics (RAPT) PT Raised to $55 at UBS

Member Login

Free News Feed